Results 1 to 10 of about 4,150 (157)
Changing Therapy for Gastrinoma [PDF]
Objective: The author analyzed potential survival determinants in gastrinoma to characterize a possible uniform staging system and to determine whether complete surgical resection improves expected survival.Summary and Background Data: Gastrinoma is an indolent yet malignant neuroendocrine tumor.
K. Radebold, P. C. Bornman
openaire +6 more sources
A solitary hepatic tumor in a 50-year-old woman, which was observed as a hemangioma, ultimately was resected because it increased in size. The tumor volume doubling time was 28.8 months over the observed period of 30 months. The histologic diagnosis was carcinoid tumor. Immunohistochemical staining showed strong focal reactivity for gastrin and diffuse
Shuhei Ikeda+6 more
openaire +3 more sources
This article reviews the role of surgical and medical management in patients with Zollinger-Ellison syndrome (ZES) due to a gastrin-secreting neuroendocrine tumor (gastrinoma). It concentrates on the status at present but also briefly reviews the changes over time in treatment approaches. Generally, surgical and medical therapy are complementary today;
Tetsuhide Ito+3 more
openaire +2 more sources
Exploratory laparotomy and a search for gastrinomas was performed in 52 patients with the Zollinger-Ellison syndrome (ZES). Gastrinoma tissue was resected in 11 patients (21%), 6 (12%) of whom appear to have been cured. After surgery, serum gastrin levels in these six patients have remained normal from 10 months to 10 years.
Stefanie Stein+5 more
openaire +4 more sources
Gastrins and gastrinomas [PDF]
Summary The past 20 years have seen gastrin attain true hormonal status. Its structure has been characterized, it has been synthesized, radioimmunoassays for its measurement in blood and tissues have been developed and its physiology and metabolism elucidated.
openaire +2 more sources
Primary Nodal Gastrinomas [PDF]
Abstract Background.—The term primary lymph node gastrinoma was first used to describe a group of patients with gastrin-producing tumors present in lymph nodes located in a well-defined anatomic region. The patients had no known primary tumors in the pancreas or gastrointestinal tract and had disease-free survival for up to 18 years. The
Marille E. Herrmann+4 more
openaire +2 more sources
Omeprazole in a Dog With Gastrinoma [PDF]
A 9‐year‐old male German Shepherd Dog was presented with the primary complaints of vomiting, profuse watery diarrhea, anorexia, and severe weight loss. The dog developed hematemesis and melena, which were unresponsive to treatment with an H2‐receptor antagonist and a gastrointestinal protectant.
Dana Brooks, Gary L. Watson
openaire +2 more sources
Medical management of gastrinoma in a cat [PDF]
Case summary A 7-year-old male castrated domestic short-haired cat was evaluated for a 4 week history of intermittent vomiting, ptyalism, lethargy and weight loss. Serum biochemistry revealed mild mixed hepatopathy. Abdominal ultrasonography identified multiple heterogeneous hepatic masses and a linear, hyperechoic focus with associated reverberation ...
Silke Hecht+3 more
openaire +4 more sources
GASTRINOMAS Clinical syndromes [PDF]
During the last 17 years about 100 gastrinomas have been diagnosed in Denmark. With background of the Danish material and the literature the clinical features and pathology of gastrinoma are reviewed and its medical and surgical treatment discussed.
openaire +3 more sources
The dog of this case was a 10-year-old Shih Tzu with refractory vomiting, diarrhea and anorexia. Endoscopy revealed an unclear at gastric angle, a stenosis at pyloric antrum and congestion in duodenal mucosa. Since abnormal shadows of irregular echo-levels were disclosed by pancreas ultrasonography, serum gastrin level was determined with a suspect of ...
Ryuji Fukushima+6 more
openaire +4 more sources